Olivier Vernon

Defensive End

Age: 30
Free Agency: 2021 (UFA)
Accrued Seasons: 8
  • 2020 Salary Cap Charge: $11,000,000 (4.81% of cap)
  • 2020 Cash Payout: $11,000,000 (5.18% of spending)
  • 2020 Cash to Cap Ratio: 1.00
  • Contract Value: $11,000,000 ($11,000,000 APY)
  • Fully Guaranteed Money: $10,750,000
  • Contract Ranking: 23/173 at DE

Current Contract

(Other, signed 2020)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202030$3,750,000$7,000,000$250,000$3,750,000$11,000,0004.8%
Total$3,750,000$7,000,000$250,000$3,750,000$11,000,000

Contract Notes

Olivier Vernon signed an $85 million contract with the Giants on March 9, 2016. Vernon received a $20 million signing bonus as part of his $40 milion in full guarantees. The total guarantees in Vernon's contract are $52.5 million. Those will become fully guarateed if he is on the roster on the 5th day of the 2018 league year.
Career Earnings: $79,930,080
Career APY: $9,991,260
Potential Earnings: $83,930,080
Total Guarantees: $91,388,080
Largest Cash Payment: $29,000,000 (2016)
Largest Cap Number: $17,000,000 (2018)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
DolphinsDraftedExpired20124$2,848,080$712,020$638,080$3,680,080129.2%$920,020
BrownsUFARenegotiated20165$85,000,000$17,000,000$40,000,000$15,500,00018.2%$15,500,000
GiantsUFATraded20165$85,000,000$17,000,000$40,000,000$53,750,00063.2%$17,916,667
BrownsOtherActive20201$11,000,000$11,000,000$10,750,000$7,000,00063.6%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Dolphins4$3,680,080$920,020$3,680,0800.0%$00.0%
Browns1$22,500,000$22,500,000$15,500,0000.0%$00.0%
Giants3$53,750,000$17,916,667$46,000,0000.0%$8,000,0000.0%

Salary Cap History

YearTeamBase SalaryProrated BonusRoster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2012Dolphins$390,000$159,520$0$0$0$549,5200.5%$1,028,080
2013Dolphins$500,000$159,520$0$10,000$0$669,5200.5%$510,000
2014Dolphins$590,000$159,520$0$10,000$0$759,5200.5%$600,000
2015Dolphins$1,532,000$159,520$0$10,000$0$1,701,5201.1%$1,542,000
2019Browns$15,250,000$0$0$250,000$0$15,500,0006.3%$15,500,000
2016Giants$1,750,000$4,000,000$7,000,000$250,000$8,750,000$13,000,0008.0%$29,000,000
2017Giants$11,750,000$4,000,000$0$250,000$11,250,000$16,000,0009.5%$11,750,000
2018Giants$12,750,000$4,000,000$0$250,000$12,000,000$17,000,0009.6%$13,000,000
2020Browns$3,750,000$7,000,000$0$250,000$3,750,000$11,000,0004.8%$11,000,000
Total$48,262,000$19,638,080$7,000,000$1,280,000$35,750,000$76,180,080$83,930,080
Dead Money History
TeamYearCap ChargeCash Paid
Giants2019$8,000,000$0
Total$8,000,000$0

Statistics

YearGames PlayedGames MissedSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
201216----38.4%60.5%2573.521390001000
2013160079.6%17.6%461111.56513160000000
2014160079.2%18.1%31156.530.59130002000
2015160081.8%17.0%41207.556.518350000000
2016160093.8%5.3%46188.554.517230001100
2017124063.4%10.4%22135.529.55111102000
2018115060.6%0.0%237739.552110011430
2019106047.9%10.8%2063.5244110001000
202011027.8%11.8%1100000000000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$1,312,000$11,000,000
Injury Adjusted$1,623,438$10,312,500
test
OTC Valuation $4.2M $8.3M $12.5M $16.6M $20.8M APY $4.5M $9.0M $13.5M $18.0M $22.5M $7,942,000 $7,840,204

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.